Dihydroergotamine injection and Lixisenatide Subcutaneous
Determining the interaction of Dihydroergotamine injection and Lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine injection-Lixtraxen Injection
- Dihydroergotamine injection-LMD
- Dihydroergotamine injection-LMD Injection
- Dihydroergotamine injection-LMX 4 Topical application
- Dihydroergotamine injection-LMX 5
- Dihydroergotamine injection-LMX 5 Topical application
- Lixisenatide Subcutaneous-Dihydroergotamine Mesylate
- Lixisenatide Subcutaneous-Dihydroergotamine nasal
- Lixisenatide Subcutaneous-Dihydroergotamine Nasal Spray
- Lixisenatide Subcutaneous-Dilacor XR
- Lixisenatide Subcutaneous-Dilantin
- Lixisenatide Subcutaneous-Dilantin Infatabs